Patents by Inventor Grzegorz Wieczorek

Grzegorz Wieczorek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
    Patent number: 10463639
    Abstract: An exemplary embodiment relates to novel protein modulators capable of altering function of the mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction. The invention provides compositions, pharmaceutical preparations and methods of correcting the cellular alteration of a mutant CFTR protein wherein the CFTR mutation is a mutation ?F508-CFTR, or another mutation of class II.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: November 5, 2019
    Assignee: INSTYTUT BIOCHEMII I BIOFIZYKI PAN
    Inventors: Norbert Odolczyk, Piotr Zielenkiewicz, Grzegorz Wieczorek, Aleksander Edelman, Danielle Tondelier, Janine Fritsch
  • Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
    Patent number: 10420738
    Abstract: An exemplary embodiment relates to novel protein modulators capable of altering function of the mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction. The invention provides compositions, pharmaceutical preparations and methods of correcting the cellular alteration of a mutant CFTR protein wherein the CFTR mutation is a mutation ?F508-CFTR, or another mutation of class II.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: September 24, 2019
    Assignee: INSTYTUT BIOCHEMII I BIOFIZYKI PAN
    Inventors: Norbert Odolczyk, Piotr Zielenkiewicz, Grzegorz Wieczorek, Aleksander Edelman, Danielle Tondelier, Janine Fritsch
  • Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
    Patent number: 10398665
    Abstract: An exemplary embodiment relates to novel protein modulators capable of altering function of the mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction. An exemplary embodiment provides compositions, pharmaceutical preparations and methods of correcting the cellular alteration of a mutant CFTR protein wherein the CFTR mutation is a mutation ?F508-CFTR, or another mutation of class II.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: September 3, 2019
    Assignee: INSTYTUT BIOCHEMII I BIOFIZYKI PAN
    Inventors: Norbert Odolczyk, Piotr Zielenkiewicz, Grzegorz Wieczorek, Aleksander Edelman, Danielle Tondelier, Janine Fritsch
  • COMPOUNDS AS MODULATORS OF A MUTANT CFTR PROTEIN AND THEIR USE FOR TREATING DISEASES ASSOCIATED WITH CFTR PROTEIN MALFUNCTION
    Publication number: 20160113896
    Abstract: An exemplary embodiment relates to novel protein modulators capable of altering function of the mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction. The invention provides compositions, pharmaceutical preparations and methods of correcting the cellular alteration of a mutant CFTR protein wherein the CFTR mutation is a mutation ?F508-CFTR, or another mutation of class II.
    Type: Application
    Filed: December 15, 2015
    Publication date: April 28, 2016
    Inventors: Norbert Odolczyk, Piotr ZIELENKIEWICZ, Grzegorz WIECZOREK, Aleksander EDELMAN, Danielle TONDELIER, Janine FRITSCH
  • COMPOUNDS AS MODULATORS OF A MUTANT CFTR PROTEIN AND THEIR USE FOR TREATING DISEASES ASSOCIATED WITH CFTR PROTEIN MALFUNCTION
    Publication number: 20160101107
    Abstract: An exemplary embodiment relates to novel protein modulators capable of altering function of the mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction. The invention provides compositions, pharmaceutical preparations and methods of correcting the cellular alteration of a mutant CFTR protein wherein the CFTR mutation is a mutation ?F508-CFTR, or another mutation of class II.
    Type: Application
    Filed: December 15, 2015
    Publication date: April 14, 2016
    Inventors: Norbert Odolczyk, Piotr ZIELENKIEWICZ, Grzegorz WIECZOREK, Aleksander EDELMAN, Danielle TONDELIER, Janine FRITSCH
  • COMPOUNDS AS MODULATORS OF A MUTANT CFTR PROTEIN AND THEIR USE FOR TREATING DISEASES ASSOCIATED WITH CFTR PROTEIN MALFUNCTION
    Publication number: 20160095869
    Abstract: An exemplary embodiment relates to novel protein modulators capable of altering function of the mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction. An exemplary embodiment provides compositions, pharmaceutical preparations and methods of correcting the cellular alteration of a mutant CFTR protein wherein the CFTR mutation is a mutation ?F508-CFTR, or another mutation of class II.
    Type: Application
    Filed: December 15, 2015
    Publication date: April 7, 2016
    Inventors: Norbert Odolczyk, Piotr ZIELENKIEWICZ, Grzegorz WIECZOREK, Aleksander EDELMAN, Danielle TONDELIER, Janine FRITSCH
  • COMPOUNDS AS MODULATORS OF A MUTANT CFTR PROTEIN AND THEIR USE FOR TREATING DISEASES ASSOCIATED WITH CFTR PROTEIN MALFUNCTION
    Publication number: 20160000778
    Abstract: An exemplary embodiment relates to novel protein modulators capable of altering function of the mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction. An exemplary embodiment provides compositions, pharmaceutical preparations and methods of correcting the cellular alteration of a mutant CFTR protein wherein the CFTR mutation is a mutation ?F508-CFTR, or another mutation of class II.
    Type: Application
    Filed: August 18, 2015
    Publication date: January 7, 2016
    Inventors: Norbert ODOLCZYK, Piotr ZIELENKIEWICZ, Grzegorz WIECZOREK, Aleksander EDELMAN, Danielle TONDELIER, Janine FRITSCH
  • COMPOUNDS AS MODULATORS OF A MUTANT CFTR PROTEIN AND THEIR USE FOR TREATING DISEASES ASSOCIATED WITH CFTR PROTEIN MALFUNCTION
    Publication number: 20130303761
    Abstract: The present invention relates to novel protein modulators capable of altering function of the mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction. The invention provides compositions, pharmaceutical preparations and methods of correcting the cellular alteration of a mutant CFTR protein wherein the CFTR mutation is a mutation AF508-CFTR, or another mutation of class II.
    Type: Application
    Filed: June 20, 2011
    Publication date: November 14, 2013
    Applicant: INSTYTUT BIOCHEMII I BIOFIZYKI PAN
    Inventors: Norbert Odolczyk, Piotr Zielenkiewicz, Grzegorz Wieczorek, Aleksander Edelman, Danielle Tondelier, Janine Fritsch